Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis

Recruiting now

Conditions studied: Sepsis Syndrome, Septic Shock, Sepsis

In brief

Sepsis is a multifactorial syndrome characterized by a dynamic course and a clinical outcome dependent on several factors, and responsible for one in five deaths worldwide. The aim of this trial is to identify new prognostic markers for the progression of sepsis to septic shock, by comparing epigenetic markers between patients who have or have not developed severe forms of sepsis. The main objective of this preliminary study is to identify prognostic markers for the progression of sepsis to septic shock, i.e. to compare targeted markers between subjects with sepsis who progress to septic shock versus subjects with sepsis who do not progress to septic shock.

Key facts

Study ID
NCT06446947
Run by
Assistance Publique Hopitaux De Marseille
People needed
25
Starts
2025-03-20
Expected to finish
2026-09-30
Last updated by the study team
2026-02-12

Who can join

Age: 45 and older, up to 75. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.